Alkermes plc.
ALKSCIK 0001520262 · last filing Jul 6, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
5,000 bought / 11,034 sold
net −6,034 sh · −$476.8K
- buys
- 1
- sells
- 3
- insiders active
- 2
Filing tape
Filed Mon, Jul 6, 2026
- −2,034 sh · $109.9K
Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
- Sold2,034Ordinary Shares@ $54.03→ 227,490 held
Filed Wed, Jul 1, 2026
- −4,000 sh · $366.9K
Hopkinson Craig C. — EVP R&D, Chief Medical Officer
- Exercised5,000Ordinary Shares@ $19.34→ 82,389 held
- Sold8,300Ordinary Shares@ $51.46→ 74,089 held
- Sold700Ordinary Shares@ $52.13→ 73,389 held
- Exercised5,000Employee Stock Option (Right to Buy)→ 1,356 held
Insiders on this tape
- Gaffin David JosephEVP, CLO, Alkermes, Inc.
- Hopkinson Craig C.EVP R&D, Chief Medical Officer
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.